Indian – Talk Bio

Actionable Insights Powered by AI

FDA Issues Warning Letter to Indian CDMO Brassica for Data Falsification and Poor Hygiene Practices

FDA, Warning Letter, Brassica Pharma, Data Falsification, Poor Hygiene, Indian CDMO, CGMP Violations